首页> 外国专利> METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA WITH USING NEUROLEPTIC COMBINED THERAPY

METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA WITH USING NEUROLEPTIC COMBINED THERAPY

机译:神经脂质联合疗法治疗精神分裂症的方法和组成

摘要

FIELD: medicine.;SUBSTANCE: group of inventions refers to medicine and aims at treating schizophrenia. A method of treating, preventing, delaying the progression or onset and/or development of schizophrenia involves administering an effective amount of a combined therapy containing dimebon and a neuroleptic specified in a group consisting of risperidone or perphenazine, into the patient. A pharmaceutically acceptable composition for treating, preventing, delaying the progression or onset and/or development of schizophrenia contains dimebon and a neuroleptic specified in a group consisting of risperidone or perphenazine. A kit for treating, preventing, delaying the progression or onset and/or development of schizophrenia contains dimebon, risperidone or perphenazine, and a package leaflet.;EFFECT: using the declared group of inventions enables increasing the clinical effect of treating schizophrenia.;8 cl
机译:领域:药物;实质:一组发明涉及药物并且旨在治疗精神分裂症。一种治疗,预防,延迟精神分裂症的进展,发作和/或发展的方法包括向患者施用有效量的联合治疗,所述联合治疗包含敌百里酮或奋乃静组成的组中指定的敌百虫和抗精神病药。用于治疗,预防,延迟精神分裂症的发展,发作和/或发展的药学上可接受的组合物包含敌百里芬和利培酮或奋乃静组成的组中指定的抗精神病药。一种用于治疗,预防,延缓精神分裂症的进展,发作和/或发展的试剂盒,其中包含地美本,利培酮或奋乃静以及包装说明书;效果:使用已声明的发明组能够提高治疗精神分裂症的临床效果; 8 CL

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号